Although both studies [190,191] were performed on prostate cancer cells, similar approaches (i.e., targeting HSP40 to inhibit HSP40–HSP70 interaction) may be efficient for breast cancer as well. This evidence concerns the gene HSPA1A and prostate carcinoma.